Esteban Rodríguez

651 total citations
17 papers, 288 citations indexed

About

Esteban Rodríguez is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Esteban Rodríguez has authored 17 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Immunology and 3 papers in Epidemiology. Recurrent topics in Esteban Rodríguez's work include Immune responses and vaccinations (5 papers), Tuberculosis Research and Epidemiology (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Esteban Rodríguez is often cited by papers focused on Immune responses and vaccinations (5 papers), Tuberculosis Research and Epidemiology (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Esteban Rodríguez collaborates with scholars based in Spain, United States and Netherlands. Esteban Rodríguez's co-authors include Eugenia Puentes, Carlos Martı́n, Mikeal L. Roose, Ryo Kubota, Nacho Aguiló, Manjunath L. Keremane, Daniel M. Jenkins, Richard F. Lee, David G. Hall and Chandrika Ramadugu and has published in prestigious journals such as Journal of the American Society of Nephrology, Frontiers in Immunology and Molecules.

In The Last Decade

Esteban Rodríguez

14 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esteban Rodríguez Spain 10 149 91 55 52 51 17 288
Kara R. Eichelberger United States 8 61 0.4× 62 0.7× 43 0.8× 13 0.3× 102 2.0× 13 262
H. Carl Gelhaus United States 9 34 0.2× 66 0.7× 150 2.7× 26 0.5× 74 1.5× 19 337
Marta Dafne Cabañero-Navalón Spain 9 157 1.1× 36 0.4× 126 2.3× 14 0.3× 39 0.8× 21 249
Manel Ben M’hadheb Tunisia 11 116 0.8× 38 0.4× 71 1.3× 13 0.3× 120 2.4× 34 300
Lorena Chiumiento Italy 6 140 0.9× 44 0.5× 29 0.5× 8 0.2× 61 1.2× 7 313
Gillian Lavelle Ireland 9 173 1.2× 36 0.4× 87 1.6× 33 0.6× 160 3.1× 10 501
Tracey Hunt Canada 7 74 0.5× 35 0.4× 51 0.9× 75 1.4× 125 2.5× 8 353
Puthayalai Treerat United States 9 55 0.4× 76 0.8× 219 4.0× 11 0.2× 74 1.5× 17 387
Inger Hee Mabuza Mathiesen Denmark 9 80 0.5× 21 0.2× 121 2.2× 13 0.3× 238 4.7× 23 496
Christina Zarek United States 7 64 0.4× 76 0.8× 43 0.8× 13 0.3× 101 2.0× 11 310

Countries citing papers authored by Esteban Rodríguez

Since Specialization
Citations

This map shows the geographic impact of Esteban Rodríguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esteban Rodríguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esteban Rodríguez more than expected).

Fields of papers citing papers by Esteban Rodríguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esteban Rodríguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esteban Rodríguez. The network helps show where Esteban Rodríguez may publish in the future.

Co-authorship network of co-authors of Esteban Rodríguez

This figure shows the co-authorship network connecting the top 25 collaborators of Esteban Rodríguez. A scholar is included among the top collaborators of Esteban Rodríguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esteban Rodríguez. Esteban Rodríguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Esteso, Gloria, Alberto Benguría, Enrique Vázquez, et al.. (2025). Cytolytic γδ T-cells and IFNγ-producing CD4-lymphocytes characterise the early response to MTBVAC tuberculosis vaccine. npj Vaccines. 10(1). 58–58. 1 indexed citations
3.
Abdelnabi, Rana, Patricia Pérez, Hendrik Jan Thibaut, et al.. (2023). Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters. Frontiers in Immunology. 14. 1163159–1163159. 4 indexed citations
4.
Uranga, Santiago, Ana Belén Gómez, Denise Nardelli‐Haefliger, et al.. (2022). Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors. Journal for ImmunoTherapy of Cancer. 10(7). e004325–e004325. 13 indexed citations
5.
Rodríguez, Esteban, et al.. (2022). A Case of Membranous Nephropathy Post SARS-CoV-2 Vaccination. Journal of the American Society of Nephrology. 33(11S). 340–341.
6.
Boudewijns, Robbert, Patricia Pérez, Dominique Van Looveren, et al.. (2022). MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters. Frontiers in Immunology. 13. 845969–845969. 16 indexed citations
7.
Esteso, Gloria, Alberto Benguría, Enrique Vázquez, et al.. (2022). BCG-activation of leukocytes is sufficient for the generation of donor-independent innate anti-tumor NK and γδ T-cells that can be further expanded in vitro. OncoImmunology. 12(1). 2160094–2160094. 12 indexed citations
8.
Dijkman, Karin, Nacho Aguiló, Charelle Boot, et al.. (2021). Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection. Cell Reports Medicine. 2(1). 100187–100187. 33 indexed citations
9.
White, Andrew, Laura Sibley, Charlotte Sarfas, et al.. (2021). MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies. npj Vaccines. 6(1). 4–4. 33 indexed citations
10.
Aguiló, Nacho, Santiago Uranga, Ana Belén Gómez, et al.. (2020). Respiratory Immunization With a Whole Cell Inactivated Vaccine Induces Functional Mucosal Immunoglobulins Against Tuberculosis in Mice and Non-human Primates. Frontiers in Microbiology. 11. 1339–1339. 13 indexed citations
11.
Romero, Beatriz, José Antonio Infantes‐Lorenzo, Mercedes Domínguez, et al.. (2019). Evaluation of the immunogenicity and efficacy of BCG and MTBVAC vaccines using a natural transmission model of tuberculosis. Veterinary Research. 50(1). 82–82. 29 indexed citations
12.
Bonjoch, Xavier, et al.. (2015). Characterization of Markers of the Progression of Human Parvovirus B19 Infection in Virus DNA-Positive Plasma Samples. Transfusion Medicine and Hemotherapy. 42(4). 233–238. 7 indexed citations
13.
14.
Mendoza, Nicolás, Rafael Sánchez‐Borrego, Joaquím Calaf, et al.. (2013). 2013 Up-date of the consensus statement of the Spanish Menopause Society on postmenopausal osteoporosis. Maturitas. 76(1). 99–107. 27 indexed citations
15.
Neyro, José Luís, et al.. (2011). [Fibromyalgia and menopause. Association or coincidence?].. PubMed. 79(9). 572–8. 2 indexed citations
16.
Velázquez, F. Raúl, Esteban Rodríguez, Yolanda Cervantes, et al.. (2004). Diarrhea Morbidity and Mortality in Mexican Children. The Pediatric Infectious Disease Journal. 23(10). S149–S155. 36 indexed citations
17.
Velázquez, F. Raúl, et al.. (2004). Enfermedad y muerte por diarrea grave en ninos mexicanos : ¿es necesaria una vacuna contra rotavirus?. 61(6). 465–473.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026